BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 7:26:00 PM | Browse: 1080 | Download: 945
Publication Name World Journal of Gastroenterology
Manuscript ID 6101
Country Italy
Received
2013-10-02 10:38
Peer-Review Started
2013-10-02 20:38
To Make the First Decision
2013-12-26 11:07
Return for Revision
2013-12-27 21:15
Revised
2014-01-15 00:03
Second Decision
2014-03-10 13:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-10 17:22
Articles in Press
2014-05-23 10:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-25 14:22
Publish the Manuscript Online
2014-07-14 17:39
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Modern approach to the clinical management of non-alcoholic fatty liver disease
Manuscript Source Invited Manuscript
All Author List Maria Del Ben, Licia Polimeni, Francesco Baratta, Daniele Pastori, Lorenzo Loffredo and Francesco Angelico
Funding Agency and Grant Number
Corresponding Author Francesco Angelico, MD, Professor of Internal Medicine, Department of Public Health and Infectious Diseases, Sapienza University, 155 viale del Policlinico, 00161 Rome, Italy. francesco.angelico@uniroma1.it
Key Words Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Insulin resistance; Oxidative stress; Cardiovascular risk; Statins; Vitamin D; Vitamin E; Pioglitazone
Core Tip Management of fatty liver has become a major challenge to healthcare systems as the consequence of the increasing rates of obesity worldwide. Several therapeutic interventions have been proposed, which include moderate weight loss, insulin sensitizer agents, lipid lowering drugs, antioxidants such as vitamin E and treatment of vitamin D3 deficiency. However, therapeutic approaches have been largely empirical and experimental trials have mostly been carried out in uncontrolled settings with small sample sizes so far. Treatment of coexisting metabolic conditions should be regarded as of paramount importance in the management of these patients.
Publish Date 2014-07-14 17:39
Citation Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8341-8350
URL http://www.wjgnet.com/1007-9327/full/v20/i26/8341.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i26.8341
Full Article (PDF) WJG-20-8341.pdf
Full Article (Word) WJG-20-8341.doc
Manuscript File 6101-Peer review(s).pdf
Answering Reviewers 6101-Answering reviewers.pdf
Copyright License Agreement 6101-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6101-Language certificate.pdf
Peer-review Report 6101-Peer review(s).pdf
Scientific Editor Work List 6101-Scientific editor work list.doc